(Q85762272)
Statements
Second line treatment in advanced non-small cell lung cancer (NSCLC): comparison of efficacy of erlotinib and chemotherapy (English)
O Fiala
M Pesek
J Finek
J Krejci
scientific article published on 01 January 2013